Sander Trenson
Overview
Explore the profile of Sander Trenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Debonnaire P, Dujardin K, Verheyen N, Pouleur A, Droogmans S, Claeys M, et al.
Eur Heart J
. 2025 Mar;
46(11):1057-1070.
PMID: 40036202
Background And Aims: In real-world, wild-type transthyretin cardiomyopathy is increasingly diagnosed in patients ≥ 80 years old (octogenarians), although being underrepresented in randomized clinical trials. Specific data on natural course...
2.
3.
Trenson S, Kahr P, Schwaiger J, Betschart P, Kuster J, Vandenberk B, et al.
Heart Rhythm
. 2024 Oct;
PMID: 39447817
Background: Cardiac resynchronization therapy (CRT) is a cornerstone in the treatment of selected heart failure patients. However, a relevant proportion of patients do not show beneficial response. Identification of simple,...
4.
Van Wauwe J, Mahy A, Craps S, Ekhteraei-Tousi S, Vrancaert P, Kemps H, et al.
Life Sci Alliance
. 2024 Sep;
7(12).
PMID: 39304345
PRDM16 is a transcription factor with histone methyltransferase activity expressed at the earliest stages of cardiac development. Pathogenic mutations in humans lead to cardiomyopathy, conduction abnormalities, and heart failure. PRDM16...
5.
Declercq A, Verstraete S, Vanwalleghem L, Trenson S
Eur Heart J Case Rep
. 2024 Sep;
8(9):ytae429.
PMID: 39279887
Background: ICI-associated myocarditis is a rare but severe and potentially life-threatening complication that typically manifests shortly after treatment initiation. It may present in many different ways, ranging from fulminant to...
6.
Sokolski M, Trenson S, Reszka K, Urban S, Sokolska J, Biering-Sorensen T, et al.
Cardiol J
. 2024 Jun;
31(4):512-521.
PMID: 38832553
Imtroduction: The high-risk population of patients with cardiovascular (CV) disease or risk factors (RF) suffering from COVID-19 is heterogeneous. Several predictors for impaired prognosis have been identified. However, with machine...
7.
Bijnens J, Trenson S, Voros G, Martens P, Ingelaere S, Betschart P, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610667
Cardiac resynchronization therapy (CRT) has evolved into an established therapy for patients with chronic heart failure and a wide QRS complex. Data on long-term outcomes over time are scarce and...
8.
Debonnaire P, Claeys M, De Paepe P, Christiaen E, Geerts B, De Geeter F, et al.
JACC CardioOncol
. 2024 Jan;
5(6):836-838.
PMID: 38204999
No abstract available.
9.
Trenson S, Voros G, Martens P, Ingelaere S, Betschart P, Voigt J, et al.
Eur J Heart Fail
. 2023 Oct;
26(2):511-520.
PMID: 37905357
Aim: Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. However, data on long-term outcome after upgrade...
10.
Wei D, Trenson S, Van Keer J, Melgarejo J, Cutsforth E, Thijs L, et al.
ESC Heart Fail
. 2022 Jan;
9(2):1216-1227.
PMID: 35005846
Aims: Cardiac allograft vasculopathy (CAV) is the major long-term complication after heart transplantation, leading to mortality and re-transplantation. As available non-invasive biomarkers are scarce for CAV screening, we aimed to...